Therapy-related acute myeloid leukemia (t-AML) is a rare but devastating complication of prior chemotherapy. That only a subset of patients treated for cancer develops t-AML suggests that these individuals may be genetically predisposed to t-AML. Alkylator-induced t-AML accounts for approximately 75% of all cases of t-AML, and is characterized by antecedent myelodysplasia and the characteristic recurrent loss of the long arm or chromosome 5 and/or chromosome 7. The long-term objective of this project is to identify genetic susceptibilities to t-AML that can be clinically translated into biomarkers for risk, or that can be used to guide therapy at the time of initial cancer diagnosis to minimize the subsequent risk of alkylator-induced t-AML. In particular, we hypothesize that genetic variation that alters the function of core stress response pathways may thereby alter cancer susceptibility. Indeed, several studies have identified genetic variants that are associated with t-AML;these studies, however, were uniformly small, reliant upon pre-existing knowledge, and limited to testing only a few plausible candidate genes. In a pilot study, we demonstrated that a genome-wide association study (GWAS) is a feasible strategy to identify genetic risk factors for t-AML, and we identified both single nucleotide polymorphisms (SNPs) and copy number variants associated with t-AML susceptibility. Here, we propose to build upon these results by undertaking a very high density GWAS to identify the complement of inherited genetic variation associated with t-AML using the Affymetrix Genome-Wide Human SNP Array 6.0. For these studies, we have amassed an unprecedented cohort of about 300 well-characterized samples from patients with t-AML, including the University of Chicago series of t-AML patients maintained in Core A of this program project. The objectives of this project will be pursued through four specific aims.
In Aim 1, we will undertake a GWAS to identify polymorphic and copy number variation associated with t-AML as compared to both cancer-free healthy control and individuals matched to cases for primary cancer, but who do not have t- AML.
In Aim 2, we will undertake a novel bioinformatic analysis of these data to identify the most likely genes and pathways implicated in the pathogenesis of t-AML.
In Aim 3, we will undertake a series of functional studies to clarify the role of the associated polymorphisms identified in Aims 1 and 2 on the etiology of t-AML.
In Aim 4, we will determine whether genetic variants found to be associated with t-AML are also associated with de novo AML. Project 2 of this application is the genome-wide analysis of copy number changes (somatically acquired mutations in t-AML). Together, these two projects provide an unmatched opportunity to study the genetics of t-AML. Because t-AML is a unique model for the geneenvironment interactions that may drive virtually all cancer, these studies may shed significant light on the genetic contribution not only towards t-AML, but to a variety of common human cancers as well.
|Clay-Gilmour, Alyssa I; Hahn, Theresa; Preus, Leah M et al. (2017) Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sex. Blood Adv 1:1717-1728|
|Churpek, Jane E; Marquez, Rafael; Neistadt, Barbara et al. (2016) Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia. Cancer 122:304-11|
|Stoddart, Angela; Qian, Zhijian; Fernald, Anthony A et al. (2016) Retroviral insertional mutagenesis identifies the del(5q) genes, CXXC5, TIFAB and ETF1, as well as the Wnt pathway, as potential targets in del(5q) myeloid neoplasms. Haematologica 101:e232-6|
|Sasaki, Mark M; Skol, Andrew D; Hungate, Eric A et al. (2016) Whole-exome Sequence Analysis Implicates Rare Il17REL Variants in Familial and Sporadic Inflammatory Bowel Disease. Inflamm Bowel Dis 22:20-7|
|Shankar, Sunita; Pitchiaya, Sethuramasundaram; Malik, Rohit et al. (2016) KRAS Engages AGO2 to Enhance Cellular Transformation. Cell Rep 14:1448-1461|
|Hungate, Eric A; Vora, Sapana R; Gamazon, Eric R et al. (2016) A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology. Nat Commun 7:10635|
|Vasanthakumar, Aparna; Arnovitz, Stephen; Marquez, Rafael et al. (2016) Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice. Blood 127:310-3|
|Sasaki, Mark M; Skol, Andrew D; Bao, Riyue et al. (2015) Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 24:1222-8|
|Wong, Jasmine C; Weinfurtner, Kelley M; Alzamora, Maria Del Pilar et al. (2015) Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis. Elife 4:|
|Sundaravel, Sriram; Duggan, Ryan; Bhagat, Tushar et al. (2015) Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes. Proc Natl Acad Sci U S A 112:E6359-68|
Showing the most recent 10 out of 221 publications